AACR 2022 roundup: Key moments and must-sees

The American Association for Cancer Research (AACR) hosted the AACR Annual Meeting 2022, April 8-13, at the New Orleans Ernest N. Morial Convention Center.

This year's meeting brought together scientists, physicians, healthcare professionals, and many others to discuss and celebrate the latest developments in cancer science and therapy from institutions all over the world. Topics discussed ranged from population science and prevention to cancer biology, translational, and clinical investigations.

In this news roundup, we have pulled together a selection of top news stories and product launches from AACR2022. Click on the headlines to learn more.

Product news and launches

Agilent highlights genomics and cell analysis solutions for cancer research at AACR 2022
Agilent Technologies showcased its portfolio of solutions for cancer research, diagnosis, and therapeutic development research innovations, including the Agilent Magnis NGS Prep System and Agilent XF Pro Analyzer

Thermo Fisher Scientific presents workflow solutions to enable novel molecular insights
Thermo Fisher Scientific shared its latest innovations in next generation cellular analysis, precise tumor profiling with digital PCR (dPCR), rapid next generation sequencing (NGS) for cancer variant analysis, and new microarray solutions for precision oncology

Bruker announces key innovations for multiplexed spatial proteomics and unbiased multiomic imaging for cancer research
Bruker Corporation launched and exhibited unique and novel capabilities for spatial multiomics, single-cell proteomics, and cell-line, tissue, and plasma proteomics cancer research

World's first Microhub makes spatial context accessible for all
The new Mica imaging platform from Leica Microsystems brings previously inaccessible experiments to all life science researchers

The Hyperion and Hyperion+ Imaging Systems
Uncover spatial relationships with high-plex imaging of 40-plus markers simultaneously at subcellular resolution

Scientist Choice Awards

• Meet your winners in the 2022 Scientists’ Choice Awards for Life Sciences
  Beckman Coulter Life Sciences, Zymo Research, and Corning Life Sciences are among those recognized at AACR 2022

News stories

• AACR President proposes new game plan to beat pancreatic cancer
• Presidential Select Symposium will examine biologic links between stress and cancer
• Recurrent non-invasive breast tumors may not always be related to the primary lesion
• KRASG12C inhibitor sotorasib may offer long-term clinical benefit in patients with non-small cell lung cancer
• Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma
• Positive results reported from four clinical trials of cellular immunotherapies
• Accounting for genetic factors that cause variations in PSA levels may improve the accuracy of prostate cancer detection
• RACE act increased the number of cancer drugs with required studies for use in pediatric patients
• Pediatric cancer patients in lower- and middle-income countries faced significantly higher mortality risk during the COVID-19 pandemic
• New CAR T-cell therapy for solid tumors was safe and showed early efficacy
• Lung cancer patients with a genetic variant linked to autoimmune disease may respond better to immunotherapy
• An AI model can help predict adverse events from new drug combinations
• Some Latino children diagnosed with acute lymphoblastic leukemia face higher risk of relapse compared to non-Latino children
• Leukemia patients with certain gene regulation patterns may be less likely to respond to CAR T therapy
• Novel COVID-19 vaccine may provide protection for cancer patients with B-cell deficiencies

Find further coverage of the AACR Annual Meeting from SelectScience by clicking here >>